The responses of intracranial pressure (ICP) to hyperbaric oxygen (HBO) therapy and arterial gas pressures were investigated.
Introduction
Cerebral vasoconstrictive effects of hyperbaric ox ygen (HBO) have been demonstrated in both clinical and experimental investigations. ", 10,12,14-16,21 ) HBO induced reduction of cerebral blood flow (CBF) and increased intracranial pressure (ICP) is beneficial in various neurological conditions when brain edema is present.","-") ICP reduction during HBO inhala tion is apparently caused by vasoconstriction, but whether the effect is directly due to HBO or to hypocapnia secondary to HBO is unknown. We, therefore, continuously recorded partial pressure of both oxygen (P02) and carbon dioxide (PCO2) using transcutaneous devices during 50-minute HBO therapy to investigate the effects of arterial gases on ICP.
Materials and Methods
The ICP and transcutaneous PO2 (PtcO2) and PCO2 (PtcCO2) were investigated in 11 patients with postoperative acute brain damage. Two patients presented with brain tumor, five subarachnoid hemorrhage, one cerebral hemorrhage, one ruptured arteriovenous malformation, and two cerebellar hemorrhage.
The patients received external ventri cular or spinal drainage and HBO therapy for postoperative neurological impairment (Table 1) . HBO therapy was performed in a multiplace hyperbaric chamber (P-1000SA, Hanyuda, Tokyo). The therapy schedule was 15-minute compression with air, 10-minute air breathing, 50-minute 100% 02 inhalation using an O2 mask at 2.5 atmospheres absolute (ATA), 10-minute decompression with O2 inhalation.
The parameters monitored were PtcO2, PtcCO2, heart rate (HR), respiratory pattern and rate (RR). PtcO2 was monitored by a TCM 1 TC oxygen monitor (Radiometer, Copenhagen, Denmark).
The PtcO2 sensor was calibrated with ambient air. PtcCO2 was monitored by a Model 634 (Kontron Medical, Zurich, Switzerland). The PtcCO2 sensor was stable and accurate during compression to 41 bar and decompression in rats,') and calibrated with two gas mixtures (5% and 10% C02 : N2 for balance, Calibrator 344, Kontron Instruments, Ltd., Zurich, Switzerland).
Arterial blood pressure (ABP) was monitored using calibrated strain-gauge P-50 trans ducers (Statham, U.S.A.) through an arterial cathe ter. The HR was determined from the electrocardio gram. The PtcCO2 and HR were expressed as mean ± SD for each patient every 5 minutes. The respiratory pattern was monitored by the impedance method and the RR averaged every 30 seconds.
The ICP was measured through the ventricular or spinal drainage catheter with the patient in the supine position using calibrated strain-gauge transducers referenced to the external auditory meatus. The baseline ICP was measured 1 hour or more before compression, to eliminate any ICP in crease due to obliteration of the external cerebrospinal fluid drainage system. All parameters including the maximum and minimum ICP values were recorded continuously by a programmable data logger (7VO7, NEC San-Ei Sokki, Tokyo) every 10 seconds before, during, and after HBO therapy (about 2 hours). The small number of patients and various illnesses prevents statistical analysis for the case studies. The t test was used to compare common variables such as HR or PtcCO2 data. Data were obtained every 10 sec onds and averaged over 5 minutes (30 points) or 1 minute (6 points) in each subject. The mean and SD were then calculated. The two variables were cor related by least square linear regression for each sub ject. Any statistical significance was then evaluated. HR is reduced by both compression and 02 inhalation, and the reduction continued during HBO inhalation. RR is not changed by HBO inhalation, but respiratory depth increased. PtcCO2 rises slightly in the first 2-5 minutes (arrow) and then decreases gradually during HBO inhalation. RR decreases during decompression.
Results
The most consistent changes during HBO therapy were a decrease in PtcCO2 and HR. The mean PtcCO2 did not change at 2.5 ATA with air, but de creased gradually during HBO inhalation ( Fig. 1) . However, continuous measurements showed the PtcCO2 rose transiently at the beginning of HBO inhalation and then decreased gradually during HBO inhalation.
The RR did not change, but the respiratory depth increased and hyperventilation continued during HBO inhalation. During decom pression after HBO inhalation, the RR reduced tran siently and the PtcCO2 increased to the previous level (Fig. 2) . The HR decreased significantly by compression to 2.5 ATA (p<0.01), and the reduc tion continued during HBO inhalation (p<0.05 compared to HR at 2.5 ATA with air). Experiment 1 (Fig. 3 ): The 10 spontaneous breathing patients usually demonstrated rapidly decreased ICP at the beginning of HBO inhalation which tended to increase gradually during HBO in halation. The PtcCO2, however, decreased gradually during HBO inhalation.
The ICP and PtcCO2 in creased during and after decompression.
ICP also decreased rapidly with 02 inhalation at 1 ATA.
Experiment 2 (Fig. 4 ): In the patient undergoing barbiturate therapy (Case 3), respiration was artifi cially controlled at 2.5 ATA with air to maintain the same PtcCO2 as at 1 ATA. When 02 at 2.5 ATA was supplied without any change in respiratory fre quency or volume, the ICP and PtcCO2 increased gradually with a transient ICP reduction.
Experiment 3 (Figs. 5 and 6): A cooperative pa tient (Case 4) was asked to reduce respiration to maintain the same PtcCO2 as at 2.5 ATA with air. The decreased ICP increased gradually toward the value at 2.5 ATA with air in spite of HBO inhala tion. When the intentional reduction in respiration was discontinued, both PtcCO2 and ICP rapidly decreased again. Two patients demonstrated no initial ICP response to HBO inhalation.
One (Case 7) showed only a slight PtcCO2 decrease when intentional hyper ventilation was requested during both 1 ATA with air and HBO inhalation. In the other patient (Case 2, PtcCO2 and ICP started to decrease about 5 minutes after HBO inhalation began, but no initial ICP reduction was seen. retention."" This CO2 retention in the respiratory center may be due to diminished red blood cell transport capacity at considerably higher 02 pres sure') and partly to diminished blood flow.') The present study confirmed that the PtcCO2 decreased gradually following a transient increase and remain ed at a lower level throughout HBO inhalation. The changes in ICP reflecting changes in the O2 and C02 pressures demonstrated by this study indicate that ICP reduction during HBO therapy is influenced by both hyperoxia and induced hypocapnia. The ICP is initially reduced by the direct vasoconstrictive effect of hyperoxia and is then maintained at a lower level mainly by induced hypocapnia during HBO inhala tion. HBO therapy is reported to promote recovery in patients with head injury or cerebral ischemia. ',' 1, `3,20) Clinically, four (Cases 7, 9-11) of our 11 patients showed neurological improvements. Animal experi ments showed that HBO has protective effects in cerebral edema or ischemia,1-19) and suppresses in creased lactate levels in the ischemic brain. ") Contreras et al.2) also showed that HBO inhalation increased cerebral glucose metabolism in a trauma tized rat brain. This indicates that HBO therapy facilitates metabolic improvement in acute brain damage.
Reduced ICP was only demonstrated during HBO inhalation and the rebound phenomenon occurred after HBO therapy in the present study. Rapid vasodilation is considered to cause the rebound phenomenon since the direct vasoconstrictive effect of HBO becomes weak and there is a rapid return to lower arterial P02 levels.',",",") Since the effect of HBO on ICP reduction is temporary, HBO therapy should be used when improvement in a hypoxic lesion is expected, rather than to reduce ICP. Moreover, in our study, low PtcCO2 could be achieved physiologically in spontaneously respirated patients. Normocapnia during HBO inhalation in artificially respirated patients will induce CO2 retention and result in increased arterial PCO2 and ICP. Therefore, HBO therapy requires care in pa tients with a high ICP and/or who are respirated artificially. [414] [415] [416] 1965 
